Domov › Crohnova bolezen › Kentucky › Louisville

Klinične študije za Crohnova bolezen v Louisville, KY

9 študij za Crohnova bolezen išče udeležence na lokacijah v Louisville in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Vključevanje udeležencevFaza 2

Gastroenterology Health Partners /ID# 284144, Louisville
Gastroenterology Health Partners /ID# 284145, New Albany · 4 mi stran

Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07697456

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3

University of Louisville Hospital ( Site 5120), Louisville

Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2

University Of Louisville, Louisville

Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06233461

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2/3

University of Louisville - MedCenter One, Louisville

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3

Gastroenterology Health Partners, Louisville
Gastroenterology Health Partners, New Albany · 4 mi stran

Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3

Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi stran

Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3

Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany · 4 mi stran

Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Vključevanje udeležencevFaza 4

University of Louisville, Louisville

Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754

Treatment of Moderate to Severe Refractory Crohn's Disease

Vključevanje udeležencevFaza 1/2

University of Louisville, Louisville

Starost 18–65 · Vsi spoli · Posodobljeno 10. dec. 2025 · NCT06721962

Študije za Crohnova bolezen v drugih mestih

Druge študije v Louisville

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.